- Home
- AMWD vs IOVA Comparison
AMWD vs IOVA Comparison
Compare AMWD & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- IOVA
- Stock Information
- Founded
- AMWD 1980
- IOVA 2007
- Country
- AMWD United States
- IOVA United States
- Employees
- AMWD N/A
- IOVA N/A
- Industry
- AMWD Forest Products
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMWD Basic Materials
- IOVA Health Care
- Exchange
- AMWD Nasdaq
- IOVA Nasdaq
- Market Cap
- AMWD 940.7M
- IOVA 975.1M
- IPO Year
- AMWD N/A
- IOVA N/A
- Fundamental
- Price
- AMWD $53.85
- IOVA $2.50
- Analyst Decision
- AMWD Buy
- IOVA Buy
- Analyst Count
- AMWD 3
- IOVA 11
- Target Price
- AMWD $70.00
- IOVA $10.50
- AVG Volume (30 Days)
- AMWD 166.5K
- IOVA 20.9M
- Earning Date
- AMWD 11-25-2025
- IOVA 11-06-2025
- Dividend Yield
- AMWD N/A
- IOVA N/A
- EPS Growth
- AMWD N/A
- IOVA N/A
- EPS
- AMWD 5.62
- IOVA N/A
- Revenue
- AMWD $1,653,503,000.00
- IOVA $250,425,000.00
- Revenue This Year
- AMWD N/A
- IOVA $65.15
- Revenue Next Year
- AMWD $3.80
- IOVA $58.47
- P/E Ratio
- AMWD $9.62
- IOVA N/A
- Revenue Growth
- AMWD N/A
- IOVA 175.62
- 52 Week Low
- AMWD $50.00
- IOVA $1.64
- 52 Week High
- AMWD $104.28
- IOVA $10.86
- Technical
- Relative Strength Index (RSI)
- AMWD 27.95
- IOVA 60.77
- Support Level
- AMWD $54.11
- IOVA $2.08
- Resistance Level
- AMWD $57.45
- IOVA $2.74
- Average True Range (ATR)
- AMWD 2.58
- IOVA 0.21
- MACD
- AMWD -1.07
- IOVA 0.06
- Stochastic Oscillator
- AMWD 4.23
- IOVA 77.55
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.